drugset / Trial / NCT00560378
Long-term Safety of Protopic in Atopic Eczema
Non-randomizedSingle-groupOpen-labelTreatment
Summary
Patients who have participated in previous studies with Tacrolimus ointment for atopic eczema are entitled to enter this four-year follow study to investigate the safety of treatment with Tacrolimus ointment 0.1%
Timeline
- Start
- 1998-06
- Primary completion
- —
- Completion
- 2005-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tacrolimus | Small molecule | 0.1 % | Topical |